Applied UV Announces Inclusion in a Multi-Million Dollar Contract Offering Throughout Non-Public Schools in The State of Washington
May 17 2022 - 8:00AM
Business Wire
Contract Is Part of the US Govt $3.5B
National EANS II Program Designed to Provide Funding For Air
Purification and Other Supplies For Non-Public Schools
Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the
“Company”), a pathogen elimination technology company that applies
the power of narrow-range ultraviolet light (“UVC”) for surface
areas and catalytic bioconversion technology for air purification
to destroy pathogens safely, thoroughly, and automatically,
announces that its wholly owned subsidiary Sterilumen has been
notified that its US Dealer, DA International, has been included in
a multi-million dollar contract which will include in its offering,
the Company’s suite of Airocide™ air purification solutions and
other related disinfection supplies to non-public schools
throughout the State of Washington.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220517005199/en/
(Graphic: Business Wire)
John F. Andrews, Applied UV’s CEO and Director, stated, “We are
extremely proud that our Airocide™ air purification suite is one of
the products being selected for the offering to the non-public
school system throughout the State of Washington. This contract
award further demonstrates the strong global brand recognition and
the growing end user business case our suite of Airocide™ product
offerings commands. We all know the impact that school closures
have had on students of all ages. The trust these schools have
placed with our Distribution Partner DA International to offer
Airocide™ further underscores our commitment to provide best in
class air purification solutions that help protect facilities,
staffs, and consumers. This is further testament to the efficacy,
ease of use and effectiveness of our air purification solutions as
the world not only reopens from the throws of this 3-year pandemic,
but more importantly, prepares against future airborne pathogens
enabling business, schools, governments, and facilities to remain
open.”
Dave Vaillancourt, DA International’s CEO, stated, “We have been
an Agent for the Airocide air purification suite for approximately
10 years. When this opportunity to bid on this EANS II contract
presented itself, we were both excited and confident about the use
of the Airocide™ air purification solutions due to its globally
proven effectiveness as well as its use by companies known all
around the world. We are thrilled to be partnering with Applied UV
expanding the business case use of this proven technology,
protecting the State of Washington’s non-public school facilities,
teachers, administrators, and students who occupy them.”
Under the terms of the Contract, DA International will begin
offering the Companies patented and globally recognized Airocide™
by Sterilumen product suite of air purification solutions as well
as other disinfection related supplies throughout non-public
schools in the state of Washington. There are approximately 700
non-public schools located throughout the state and once the
initial contract award has been fulfilled, it could be expanded.
Together as part of the American Rescue Plan, the Emergency
Assistance for Non-Public Schools program (EANS II), the US
government has made available over $3.5B of funding to address the
educational and business disruptions caused by the Covid-19
pandemic, which includes improving ventilation systems, including
mobile and fixed air purification systems to ensure healthy air in
non-public schools and workplaces. DA International was one of four
authorized suppliers for each of the three areas (out of 13 areas
total) covered by the EANS II tendering process, only one area
covers the Airocide products.
About Applied UV
Applied UV is focused on the development and acquisition of
technology that address infection control in the healthcare,
hospitality, commercial and municipal markets. The Company has two
wholly owned subsidiaries - SteriLumen, Inc. (“SteriLumen”) and
Munn Works, LLC (“Munn Works”). SteriLumen’s connected platform for
Data Driven Disinfection™ applies the power of ultraviolet light
(UVC) to destroy pathogens safely, thoroughly, and automatically,
addressing the challenge of healthcare-acquired infections
("HAIs"). Targeted for use in facilities that have high customer
turnover such as hospitals, hotels, commercial facilities, and
other public spaces, the Company’s Lumicide™ platform uses UVC LEDs
in several patented designs for infection control in and around
high-traffic areas, including sinks and restrooms, killing
bacteria, viruses, and other pathogens residing on hard surfaces
within devices’ proximity. The Company’s patented in-drain
disinfection device, Lumicide Drain, is the only product on the
market that addresses this critical pathogen intensive location.
SteriLumen’s Airocide® air purification devices are research
backed, clinically proven and developed for NASA with assistance
from the University of Wisconsin. Airocide® is listed as an FDA
Class II Medical device, utilizes a proprietary photocatalytic
(PCO) bioconversion technology that draws air into a reaction
chamber that converts damaging molds, microorganisms, dangerous
airborne pathogens, destructive VOCs, allergens, odors and
biological gasses into harmless water vapor and green carbon
dioxide without producing ozone or other harmful byproducts.
Airocide® applications include healthcare, hospitality, grocery
chains, wine making facilities, commercial real estate, schools,
dental offices, post-harvest, grocery, cannabis facilities and
homes. For more information about Applied UV, Inc., and its
subsidiaries, please visit the following website:
https://www.applieduvinc.com/.
Forward-Looking Statements
The information contained herein may contain “forward‐looking
statements.” Forward‐looking statements reflect the current view
about future events. When used in this press release, the words
“anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,”
“plan,” or the negative of these terms and similar expressions, as
they relate to us or our management, identify forward‐looking
statements. Such statements include, but are not limited to,
statements contained in this press release relating to the view of
management of Applied UV concerning its business strategy, future
operating results and liquidity and capital resources outlook.
Forward‐looking statements are based on the Company’s current
expectations and assumptions regarding its business, the economy
and other future conditions. Because forward–looking statements
relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict.
The Company’s actual results may differ materially from those
contemplated by the forward‐looking statements. They are neither
statements of historical fact nor guarantees of assurance of future
performance. We caution you therefore against relying on any of
these forward‐looking statements. Factors or events that could
cause the Company’s actual results to differ may emerge from time
to time, and it is not possible for the Company to predict all of
them. The Company cannot guarantee future results, levels of
activity, performance, or achievements. Except as required by
applicable law, including the securities laws of the United States,
the Company does not intend to update any of the forward‐looking
statements to conform these statements to actual results.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220517005199/en/
Applied UV Inc. John F. Andrews Applied UV CEO, Director
john.andrews@applieduvinc.com
Brett Maas, Managing Principal Hayden IR brett@haydenir.com
(646) 536-7331
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Apr 2023 to Apr 2024